HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS
摘要:
The invention provides compounds of formulae A, B, and C as described herein that inhibit monocarboxylate transporters, such as MCT1 and MCT4. Compounds of the invention can be used for treatment of a condition in a patient, wherein the condition is characterized by the heightened activity or by the high prevalence of MCT1 and/or MCT4, such as cancer or type II diabetes.
公开/授权文献
信息查询
0/0